II.
Review and Approval of Agenda
III.
OPLC and/or Board Administration Updates
2.
Commissioner Rochefort
3.
Commissioner Laliberte
4.
Commissioner Harrington
A.
Approval of the Public Minutes from the March 29, 2023 Meeting
1.
CVS, Manchester, Lic #0168
2.
CVS, Nashua, Lic# 0235
3.
CVS, Nashua, Lic # 0405
4.
Genoa Healthcare, Keene, Lic #04564
5.
Genoa Healthcare, Rochester, Lic #0809
6.
Hannaford Pharmacy, Manchester, Lic #0366
7.
Rite Aid, Kingston, Lic # 0166
8.
Rite Aid, Manchester, Lic # 0122
9.
Rite Aid, Raymond, Lic #0373
10.
Rite Aid, Manchester, Lic # 0522
11.
Rite Aid, Derry, Lic #0695
12.
Rite Aid, Concord, Lic # 0713
13.
Rite Aid, Plaistow, Lic # 0729
14.
Walgreens, Concord, Lic # 0750
15.
Walmart, Concord, Lic # 0406
16.
Rite Aid, Pelham, Lic # 0545
C.
Collaborative Practice
1.
Dharmangini Gunjan Majmundar, Lic # 3284
1.
Northeast Rehabilitation Hospital Network, Salem, Lic # 0491 and Nashua, Lic # 0779
1.
Fall 2022 NABP Task Force and Work Group Reports
2.
New, One-Time Training Requirement for DEA-Registered Practitioners on the Treatment and Management of Patients With Opioid or Other Substance Use Disorders
3.
Board of Pharmacy E-Prescribing Concerns Regarding Resolution No. 118-2-22
4.
Well-Being Index for Pharmacy Personell
5.
New Digital Network to Simplify Process of Achieving DSCSA Compliance
7.
Deadline Approaching – Submissions for 2023-2024 Committees and Task Forces
F.
Automated System Registration
1.
Concept Pharmacy, Nashua
2.
Concept Pharmacy, Bedford
G.
Additional Consent Items
1.
Declaratory Ruling for Disposal of Controlled Drugs
A.
Cheshire Medical Center
B.
Show Cause Hearing 10:00 a.m.- Conrad Pszczola, Lic # 4260
VI.
Rules Review and Other Legislative Topics
A.
Public Hearing on Ph 601.10 at 9:30 a.m.
B.
Ph 200- initial Proposal
C.
Ph 1700- CQI Requirements
VII.
Licensure Approval (if applicable)
A.
New Permit-Central Admixture Pharmacy Services, Inc
B.
New Pharmacy- Parkland Medical Center, Plaistow
C.
Initial Sterile Application- Bioscrip Infusion Services
A.
HHS Guidance question from Shelley Tustison
B.
Ph 2400 Pharmacist Initiation and Dispensing of Hormonal Contraceptives
C.
COVID-19 Public Health Emergency Transition Roadmap
D.
Request for BOP's USP 797/800 testing requirements and inspection checklist
F.
Proposed Amendments to the NABP Constitution and Bylaws NABP 119th Annual Meeting, May 10-12, 2023
G.
NABP- Request for information
H.
Refill limits on Testosterone
I.
Proposed Resolutions, NABP 119th Annual Meeting, May 10-12, 2023, Nashville, TN
J.
When Should a Control Inventory be Done?
K.
How Does the Board Make NABP Aware of Rules Changes
L.
USP 797/800 -Compounding Discussion
M.
Possible Problem with RSA 318-B